ArticleAmerican journal of nephrology2026
A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Desidustat's Efficacy and Safety in Non-Dialysis Chronic Kidney Disease Patients with Anemia.
Jie Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.